Oxford BioTherapeutics Advances Oncology with Innovative TherapiesOxford BioTherapeutics Advances Oncology with Innovative Therapies
The network for creativity
Join 1.25M professional creatives like you
Connect with clients, get discovered, and run your business 100% commission-free
Creatives on Contra have earned over $150M and we are just getting started
Oxford BioTherapeutics is a biotechnology company focused on developing next-generation oncology treatments through targeted therapies, including antibody-drug conjugates (ADCs), immuno-oncology, T-cell engagers (TCEs), and radiopharmaceuticals.
The goal was to create a restrained, professional digital experience built around stakeholder-focused content and visually clear scientific communication. The hero illustration depicts a T cell activating after detecting a tumor cell, reflecting the company’s work on redefining the cancer–immune synapse and exploring novel immune checkpoint mechanisms.
Post image
Back to feed
The network for creativity
Join 1.25M professional creatives like you
Connect with clients, get discovered, and run your business 100% commission-free
Creatives on Contra have earned over $150M and we are just getting started